In 2023, Germany led global hospital discharges for leiomyoma of the uterus at 32.32 units, followed by Poland at 16.26 units and Spain at 12.05 units. The United Kingdom, Chile, and Switzerland reported figures of 11.06, 8.08, and 3.71 units respectively. The data highlights Germany's significant share, despite a 2.04% decline from the previous year. Notably, Israel saw an increase of 4.09%. The Netherlands, Hungary, Slovakia, and Iceland experienced declines exceeding 3% year-over-year.
Looking ahead, monitoring shifts in healthcare policies, treatment advancements, and demographic changes will be pivotal in understanding future trends in hospital discharges for leiomyoma of the uterus globally.
Top countries in Hospital Discharges for Leiomyoma of Uterus Share by Country (Units (Hospital Discharges))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 32.32 | 2023 | -0.26% | -2.04% | View data |
| 2 | 2 Poland | 16.26 | 2023 | +5.59% | +0.14% | View data |
| 3 | 3 Spain | 12.05 | 2023 | +2.15% | -0.7% | View data |
| 4 | 4 United Kingdom | 11.06 | 2023 | -1.03% | -1.02% | View data |
| 5 | 5 Chile | 8.08 | 2023 | +7.08% | -0.59% | View data |
| 6 | 6 Switzerland | 3.71 | 2023 | +2.93% | +0.43% | View data |
| 7 | 7 Austria | 2.96 | 2023 | +3.03% | +0.2% | View data |
| 8 | 8 Belgium | 2.88 | 2023 | +0.38% | -1.68% | View data |
| 9 | 9 Netherlands | 2.21 | 2023 | +0.44% | -3.02% | View data |
| 10 | 10 Hungary | 2.18 | 2023 | +0.5% | -3.15% | View data |
